Revolution Medicines
Revolution Medicines is a clinical-stage biopharmaceutical company developing targeted therapies, primarily RAS inhibitors, for cancers driven by RAS gene mutations.
Standing...
Stories...
Aug 26, 2026
Far Right
The FDA approved its pancreatic cancer drug Rasonque after a trial showed doubled patient survival.
This medical breakthrough is welcomed by Religious Zionism as a positive development, though it is peripheral to the political news cycle.